Financial News
AI-generated market updates and breaking coverage across our tracked tickers.
Lead Story
Johnson & Johnson (JNJ) Market Update: Pre-Market Analysis Following Auris Ruling and Promising Colorectal Cancer Data
Johnson & Johnson (JNJ) sees modest pre-market gains amid mixed news, including a court-ordered recalculation of damages in the Auris Health case and positive clinical trial results. Our analysis covers the key developments and investment considerations for JNJ.
2m readJan 14
Jan 13
Jan 13
Johnson & Johnson (JNJ) Market Update: Pre-Market Analysis and Investment Strategy
2mJNJ• Bearish
Jan 12
Jan 12
Johnson & Johnson (JNJ) Market Update: Navigating a Holding Pattern
2mJNJ• Bullish
Jan 11
Jan 11
Johnson & Johnson (JNJ) Market Update: Navigating a Complex Landscape
2mJNJ• Bullish
Jan 10
Jan 10
Johnson & Johnson (JNJ) Market Update: Navigating a Complex Landscape
2mJNJ• Bearish
Jan 9
Jan 9
JNJ Market Update
1mJNJ• Bullish
Jan 8
Jan 8
Johnson & Johnson (JNJ) Market Update: Analyzing Recent Performance and Future Outlook
2mJNJ• Bearish
Jan 7
Jan 7
Johnson & Johnson (JNJ) Market Update: Analyzing After-Hours Performance and Future Outlook
2mJNJ• Bullish
Jan 5
Jan 5
JNJ Market Update: After-Hours Dip Raises Questions Ahead of Next Session
2mJNJ• Bullish
Jan 4
Jan 4
Johnson & Johnson (JNJ) Market Update: Steady Sailing Amidst Shifting Tides
2mJNJ• Bullish